The Asia Pacific biopsy devices market is expected to reach US$ 744.80 million by 2027 from US$ 440.88 million in 2019; it is estimated to grow at a CAGR of 6.9% from 2020 to 2027.
The biopsy devices marketis growing primarily due to are increasing incidence of cancer, surging demand of minimally invasive surgeries, and government support and initiativesin the region. Factors such limitations associated to biopsy devices hamper the growth of the market. Additionally, increasing awareness regarding the need of early disease detectionand consistent improvements in product designsare likely to fuel the growth of the Asia Pacific biopsy devices marketduring the forecast period.
Biopsy is a medical examination generally implemented by surgeons, interventional radiologists, or interventional cardiologists to extract sample cells or tissues that are use for the identification anddetection of a disease. The tissue is generally observed under a microscope by pathologists, or it can also be examined through chemical tests. Biopsies are most commonly performed to identify cancerous and inflammatory conditions.
There has been an exponential rise in cancer cases in Asian countries since the last few decades. For instance, lung cancer has been the leading cause of death people in Taiwan. These increasing cases result huge burden on healthcare systems every year as they need to treat huge number of people. Logistics is the major challenge faced in this region, as the scans and tumor marking were performed by giving local anesthesia to the patient in the radiology department then the transport of patient can cause pneumothorax and hemothorax as well as simply discomfort of anxiety. In some cases, it results in dislocation of the marker. Thus, to make up for the compromised accuracy through dislocation, physicians need to search the nodules manually by inserting their fingers into the incision and palpating the nodule. ARTIS phenol isa product with the ability to localize nodules during the intervention without moving the patient. The live imaging brought several advantages with safer process and advancement in the therapies. The main focus in the future is about reducing risk, whether through prevention, screening, or the support of advanced imaging to provide life-saving levels of detail.
Countries in AsiaPacific are witnessing huge challenge in the form of the growing COVID-19 cases. According to the WHO, due to the rapidly changing risk of COVID-19 affected countries and constantly controlling outbreak trends, any additional measures taken to contain the outbreak are significantly interfering with international travel and trade. This has adversely influenced all industries, including cancer diagnostics. According to an article published in April 2020, cancer patients in Delhi, India,have been facing immense problems as their treatments and diagnosis, and progress-checking tests were postponed as hospitals are busy managing the constantly rising COVID-19 cases.
In 2019, the needle-based biopsy segment accounted for the largest share of the biopsy devices market. The growth of the segmental market is attributed to the rising adoption of this type of biopsy due to its high accuracy and minimal injury risks. Further, the European market for this segment is also likely to witness the fastest CAGR during the forecast years.
A few of the significant secondary sources associated with the Asia Pacific biopsy devices marketreport are the World Health Organization (WHO), National Center for Biotechnology Information (NCBI), and Globocan report.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Biopsy Devices Market - By Product
1.3.2 Asia Pacific Biopsy Devices Market - By Technology
1.3.3 Asia Pacific Biopsy Devices Market - By Application
1.3.4 Asia Pacific Biopsy Devices Market - By Country
2. Asia Pacific Biopsy Devices Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Biopsy Devices Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Biopsy Devices Market - Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Biopsy Devices Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Incidence of Cancer
5.1.2 Government Support and Initiatives
5.1.3 Surging Demand For Minimally Invasive Surgery
5.2 Key Market Restraints
5.2.1 Limitations Associated with Biopsy
5.3 Key Market Opportunities
5.3.1 Increasing Awareness Regarding Early Disease Detection
5.4 Future Trends
5.4.1 Consistent Improvement in Product Designs
5.5 Impact Analysis
6. Biopsy Devices Market - Asia Pacific Analysis
6.1 Asia Pacific Biopsy Devices Market Revenue Forecasts and Analysis
7. Asia Pacific Biopsy Devices Market Analysis and Forecasts To 2027 - By Product
7.1 Overview
7.2 Asia Pacific Biopsy Devices market, By Product 2019 & 2027 (%)
7.2.1 Asia Pacific Biopsy Devices Market Revenue and Forecasts to 2027, By Product (US$ Mn)
7.2.2 Needle-Based Biopsy Market Revenue and Forecasts to 2027, By Type (US$ Million)
7.3 Needle-Based Biopsy
7.3.1 Overview
7.3.2 Asia Pacific Needle-Based Biopsy Market Revenue and Forecast to 2027 (US$ Mn)
7.3.3 Core Biopsy Devices
7.3.3.1 Overview
7.3.3.2 Asia Pacific Core Biopsy Devices Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.4 Aspiration Biopsy Needles
7.3.4.1 Overview
7.3.4.2 Asia Pacific Aspiration Biopsy Needles Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.5 Vacuum Assisted Biopsy (VAB) Devices
7.3.5.1 Overview
7.3.5.2 Asia Pacific Vacuum Assisted Biopsy (VAB) Devices Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Localization Wires
7.4.1 Overview
7.4.2 Asia Pacific Localization Wires Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Procedure Trays
7.5.1 Overview
7.5.2 Asia Pacific Procedure Trays Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Others
7.6.1 Overview
7.6.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. Asia Pacific Biopsy Devices Market Analysis - By Technology
8.1 Overview
8.2 Asia Pacific Biopsy Devices Market, By Technology 2019-2027 (%)
8.2.1 Asia Pacific Biopsy Market Devices Revenue and Forecasts to 2027, By Technology (US$ Mn)
8.3 CT Scan
8.3.1 Overview
8.3.2 Asia Pacific CT Scan Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Ultrasound Guided Biopsy
8.4.1 Overview
8.4.2 Asia Pacific Ultrasound Guided Biopsy Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Stereotactic Guided Biopsy
8.5.1 Overview
8.5.2 Asia Pacific Stereotactic Guided Biopsy Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 MRI Guided Biopsy
8.6.1 Overview
8.6.2 Asia Pacific MRI Guided Biopsy Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Others
8.7.1 Overview
8.7.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Asia Pacific Biopsy Devices Market Analysis - By Application
9.1 Overview
9.2 Asia Pacific Biopsy Devices Market, By Application 2019-2027 (%)
9.2.1 Asia Pacific Biopsy Devices Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.3 Lungs Biopsy
9.3.1 Overview
9.3.2 Asia Pacific Lungs Biopsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Kidney Biopsy
9.4.1 Overview
9.4.2 Asia Pacific Kidney Biopsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Liver Biopsy
9.5.1 Overview
9.5.2 Asia Pacific Liver Biopsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Breast Biopsy
9.6.1 Overview
9.6.2 Asia Pacific Breast Biopsy Market Revenue and Forecasts to 2027 (US$ Mn)
9.7 Others
9.7.1 Overview
9.7.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. Biopsy Devices Market Revenue and Forecasts To 2027 - Geographical Analysis
10.1 Asia Pacific Biopsy Devices Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 Asia-Pacific: Biopsy Devices Market - Revenue and Forecast to 2027 (USD Millions)
10.1.6 Asia-Pacific: Biopsy Devices Market, by Country, 2019 & 2027 (%)
10.1.7 China: Biopsy Devices Market
10.1.7.1 China: Biopsy Devices Market - Revenue and Forecast to 2027 (USD Millions)
10.1.7.2 China: Biopsy Devices Market, by Product, 2018-2027 (USD Million)
10.1.7.2.1 China: Needle-Based Biopsy Devices Market, by Type, 2018-2027 (USD Million)
10.1.7.3 China: Biopsy Devices, Market, by Technology, 2018-2027 (USD Million)
10.1.7.4 China: Biopsy Devices Market, by Application, 2018-2027 (USD Million)
10.1.8 Japan: Biopsy Devices Market
10.1.8.1 Japan: Biopsy Devices Market - Revenue and Forecast to 2027 (USD Millions)
10.1.8.2 Japan: Biopsy Devices Market, by Product, 2018-2027 (USD Million)
10.1.8.2.1 Japan: Needle-Based Biopsy Devices Market, by Type, 2018-2027 (USD Million)
10.1.8.3 Japan: Biopsy Devices, Market, by Technology, 2018-2027 (USD Million)
10.1.8.4 Japan: Biopsy Devices Market, by Application, 2018-2027 (USD Million)
10.1.9 India: Biopsy Devices Market
10.1.9.1 India: Biopsy Devices Market - Revenue and Forecast to 2027 (USD Millions)
10.1.9.2 India: Biopsy Devices Market, by Product, 2018-2027 (USD Million)
10.1.9.2.1 India: Needle-Based Biopsy Devices Market, by Type, 2018-2027 (USD Million)
10.1.9.3 India: Biopsy Devices, Market, by Technology, 2018-2027 (USD Million)
10.1.9.4 India: Biopsy Devices Market, by Application, 2018-2027 (USD Million)
10.1.10 South Korea: Biopsy Devices Market
10.1.10.1 South Korea: Biopsy Devices Market - Revenue and Forecast to 2027 (USD Millions)
10.1.10.2 South Korea: Biopsy Devices Market, by Product, 2018-2027 (USD Million)
10.1.10.2.1 South Korea: Needle-Based Biopsy Devices Market, by Type, 2018-2027 (USD Million)
10.1.10.3 South Korea: Biopsy Devices, Market, by Technology, 2018-2027 (USD Million)
10.1.10.4 South Korea: Biopsy Devices Market, by Application, 2018-2027 (USD Million)
10.1.11 Australia: Biopsy Devices Market
10.1.11.1 Australia: Biopsy Devices Market - Revenue and Forecast to 2027 (USD Millions)
10.1.11.2 Australia: Biopsy Devices Market, by Product, 2018-2027 (USD Million)
10.1.11.2.1 Australia: Needle-Based Biopsy Devices Market, by Type, 2018-2027 (USD Million)
10.1.11.3 Australia: Biopsy Devices, Market, by Technology, 2018-2027 (USD Million)
10.1.11.4 Australia: Biopsy Devices Market, by Application, 2018-2027 (USD Million)
11. Impact Of COVID-19 Pandemic on Asia Pacific Biopsy Devices Market
11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 B. Braun Melsungen AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Fujifilm Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Hologic, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Danaher
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Biopsy Devices Market Revenue and Forecasts To 2027, By Product (US$ Mn)
Table 2. Needle-Based Biopsy Market Revenue And Forecasts to 2027, By Type (US$ Million)
Table 3. Asia Pacific Biopsy Devices Market Revenue and Forecasts To 2027, By Technology (US$ Mn)
Table 4. Asia Pacific Biopsy Devices Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 9. China Biopsy Devices Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 10. China Needle-Based Biopsy Devices Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 11. China Biopsy Devices Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 12. China Biopsy Devices Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 13. Japan Biopsy Devices Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 14. Japan Needle-Based Biopsy Devices Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 15. Japan Biopsy Devices Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 16. Japan Biopsy Devices Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 17. India Biopsy Devices Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 18. India Needle-Based Biopsy Devices Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 19. India Biopsy Devices Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 20. India Biopsy Devices Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 21. South Korea Biopsy Devices Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 22. South Korea Needle-Based Biopsy Devices Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 23. South Korea Biopsy Devices Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 24. South Korea Biopsy Devices Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 25. Incidence, Mortality and Prevalence by cancer site, Australia, 2018
Table 26. Australia Biopsy Devices Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 27. Australia Needle-Based Biopsy Devices Market, by Type- Revenue and Forecast to 2027 (USD Million)
Table 28. Australia Biopsy Devices Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 29. Australia Biopsy Devices Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 30. Glossary of Terms, Biopsy Devices Market
The List of Companies - Asia Pacific Biopsy Devices Market
1. B. Braun Melsungen AG
2. Medtronic
3. Fujifilm Corporation
4. Danaher
5. Hologic, Inc.
Â